Back
Protagonist Therapeutics, Inc. Stock Price Chart
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
56
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$87.33
Seasonality Move:
28.35%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
Protagonist Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 87.42 | Sell |
| 20-day SMA: | 84.83 | Buy |
| 50-day SMA: | 77.39 | Buy |
| 200-day SMA: | 57.47 | Buy |
| 8-day EMA: | 86.5 | Sell |
| 20-day EMA: | 84.42 | Buy |
| 50-day EMA: | 77.93 | Buy |
| 200-day EMA: | 60.95 | Buy |
Protagonist Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.92 | Buy |
| Relative Strength Index (14 RSI): | 58.12 | Buy |
| Chaikin Money Flow: | 93595 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (79.09 - 87.49) | Buy |
| Bollinger Bands (100): | (55.24 - 79.02) | Buy |
Protagonist Therapeutics, Inc. Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics, Inc. Stock
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 86.07 while PTGX 8-day simple moving average is 87.42, which is a Sell signal.
-
The stock price of PTGX is 86.07 while Protagonist Therapeutics, Inc. 20-day SMA is 84.83, which makes it a Buy.
-
Protagonist Therapeutics, Inc. 50-day simple moving average is 77.39 while PTGX share price is 86.07, making it a Buy technically.
-
PTGX stock price is 86.07 and Protagonist Therapeutics, Inc. 200-day simple moving average is 57.47, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Buy
56
Protagonist Therapeutics, Inc. (PTGX)
is a Buy
Is Protagonist Therapeutics, Inc. a Buy or a Sell?
-
Protagonist Therapeutics, Inc. stock is rated a BuyThe current Protagonist Therapeutics, Inc. [PTGX] share price is $86.07. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Protagonist Therapeutics, Inc. Stock Info
Market Cap:
5.4B
Price in USD:
86.07
Share Volume:
715.5K
Protagonist Therapeutics, Inc. 52-Week Range
52-Week High:
93.25
52-Week Low:
33.70
Buy
56
Protagonist Therapeutics, Inc. (PTGX)
is a Buy
Protagonist Therapeutics, Inc. Share Price Forecast
-
What is the Protagonist Therapeutics, Inc. stock price today?The Protagonist Therapeutics, Inc. stock price is 86.07 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics, Inc. is not overvalued.
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 86.07 while PTGX 8-day exponential moving average is 86.50, which is a Sell signal.
-
The stock price of PTGX is 86.07 while Protagonist Therapeutics, Inc. 20-day EMA is 84.42, which makes it a Buy.
-
Protagonist Therapeutics, Inc. 50-day exponential moving average is 77.93 while PTGX share price is 86.07, making it a Buy technically.
-
PTGX stock price is 86.07 and Protagonist Therapeutics, Inc. 200-day simple moving average is 60.95, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics, Inc.
Is Protagonist Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.50 per share, and an increase next year of $2.43 per share.
Technical Analysis of Protagonist Therapeutics, Inc.
Should I short Protagonist Therapeutics, Inc. stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is 2.92, suggesting Protagonist Therapeutics, Inc. is a Buy
-
Protagonist Therapeutics, Inc. Relative Strength Index (RSI) is 58.12, which suggest Protagonist Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Protagonist Therapeutics, Inc. is (79.09 - 87.49), which suggest Protagonist Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics, Inc. is (55.24 - 79.02), which suggest Protagonist Therapeutics, Inc. is a Buy
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.